Efficacy and Safety of a Tubeless AID System Compared With Pump Therapy With CGM in the Treatment of Type 1 Diabetes in Adults With Suboptimal Glycemia: A Randomized, Parallel-Group Clinical Trial

Use of the tubeless AID system led to improved glycemic outcomes compared with pump therapy with CGM among adults with type 1 diabetes, underscoring the clinical benefit of AID and bolstering recommendations to establish AID systems as preferred therapy for this population.

Authors

Institutions

Publication Details

Journal
Diabetes Care
Published
2024-10-18
DOI
https://doi.org/10.2337/dc24-1550
Citations
32
Primary Topic
Diabetes Management and Research
Type
article
Field-Weighted Citation Impact
11.45

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy and Safety of a Tubeless AID System Compared With Pump Therapy With CGM in the Treatment of Type 1 Diabetes in Adults With Suboptimal Glycemia: A Randomized, Parallel-Group Clinical Trial

Liana Hsu, Faisal Malik, Orianne Villard, E. Dunn et al.
32 citations
Diabetes Care
Diabetes Management and Research
11.45
article

Efficacy and Safety of a Tubeless AID System Compared With Pump Therapy With CGM in the Treatment of Type 1 Diabetes in Adults With Suboptimal Glycemia: A Randomized, Parallel-Group Clinical Trial

Liana Hsu, Faisal Malik, Orianne Villard, E. Dunn, Bruce W. Bode, Kaisa Kivilaid, Lindsey R. Conroy, Jonathan G. Ownby, Ryan Kingman, Alexis Moore, Trang T. Ly, Tiphaine Vidal-Trécan, Halis Kaan Aktürk, Catherine Petit, Morgan Fuller, Rayhan Lal, Monica Lewis, Christine Turcotte, Cate Wilby, Michael S. Hughes, Mary C. Oliveri, Irl B. Hirsch, Damon R. Reed, Nina Shelton, Danielle Oliver, Manal Al Masri, Sylvie Fimbel, Marcelle Desienne Siadoua, Louise Ambler-Osborn, Joseph H. Johnson, Kristin Castorino, Fatemeh Movaghari Pour, Jean‐Pierre Riveline, Mei Mei Church, Meaghan Stumpf, Éric Renard, Xiaofu Dong, Jean–François Gautier, Elvira Isganaitis, Anne Farret, Christopher M. Herndon, Mark Kipnes, Todd Vienneau, Bruce A. Buckingham, Ashleigh Downs, Lisa Norlander, Terri Ryan, Jelena Kravarusic, LAUREN M. HUYETT, Grazia Aleppo, Lori M. Laffel, Ashley Thorsell, Krizia Rosas, Bailey Suh, Charline Potier, Samsam C. Penn, Ruth S. Weinstock, Bonnie Dumais, Christie Beatson, Patali Mandava, Ryan Shoemaker, Suzan Bzdick, Lisa K. Volkening, Suzanne Mulvey, Amna Salhin, Lubna Qamar, Sheri Stone, Djamila Bellili, Xenia Averkiou, Tanner Bloks, Jade Doolan, Eduardo Guevara, Sue A. Brown, Amanda Maxson, Hal Joseph, Joseph Hernandez, Sonya Walker, C. Alix, Justo Juliá, Stefanie Herrmann, Stephanie Beltran, Kysa M. Christie, Laura Kollar, Redhouane Hami, Courtney Tabb, Hannah Blanscet, Vanessa Ramon, Chad Hirchak, Evelyn Goroza, Darya Wodetzki
article en
32 citations

Abstract

Use of the tubeless AID system led to improved glycemic outcomes compared with pump therapy with CGM among adults with type 1 diabetes, underscoring the clinical benefit of AID and bolstering recommendations to establish AID systems as preferred therapy for this population.

Diabetes CareVol. 47(12)
Northwestern University (US), Joslin Diabetes Center (US), Centre National de la Recherche Scientifique (FR), Harvard University (US), Inserm (FR), Université de Montpellier (FR), University of Washington (US), SUNY Upstate Medical University (US), Université Paris Cité (FR), Université Paris-Saclay (FR), Sorbonne Paris Cité (FR), Centre Hospitalier Universitaire de Montpellier (FR), Sansum Diabetes Research Institute (US), Atlanta Diabetes Associates (US), Hôpital Fernand-Widal (FR), Centre Hospitalier Sud Francilien (FR), Hôpital Lariboisière (FR), Diabetes & Glandular Disease Clinic (US), Stanford Medicine (US), Insulet (United States) (US), Institut de Génomique Fonctionnelle (FR), University of Virginia (US), University of Colorado Anschutz Medical Campus (US), Stanford University (US)
Amgen, Eli Lilly and Company, Pfizer, AstraZeneca, Sanofi, Gilead Sciences, Vertex Pharmaceuticals, Insulet Corporation, MannKind Corporation, Quest Diagnostics, Dexcom, Kowa Company, Inventiva Pharma, Tandem Diabetes Care, Novo Nordisk, Abbott Diabetes Care
Good health and well-being
Openalex Percentile: Top 1%
Diabetes Management and Research
11.45
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.